Arformoterol Tartrate Solution
Product Images NDC 42571-464

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 42571-464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Arformoterol-crt.jpg (Arformoterol Crt)

FDA Label Image

Arformoterol-figa.jpg (Arformoterol Figa)

This is not a readable text.*

FDA Label Image

Arformoterol-figb.jpg (Arformoterol Figb)

This information shows the mean change in forced expiratory volume in one second (FEV1) from baseline for two different treatments over time post-dose. The data compares a placebo group (n=143) with a baseline FEV1 of 1.20 liters, and a group receiving 15 micrograms of Arformoterol Tartrate Inhalation Solution twice daily (n=141) with a baseline FEV1 of 1.15 liters. The measurements are presented in percentage changes from baseline for different hours post-dose.*

FDA Label Image

Arformoterol-insta.jpg (Arformoterol Insta)

FDA Label Image

Arformoterol-instb.jpg (Arformoterol Instb)

FDA Label Image

Arformoterol-instc.jpg (Arformoterol Instc)

FDA Label Image

Arformoterol-instd.jpg (Arformoterol Instd)

FDA Label Image

Arformoterol-inste.jpg (Arformoterol Inste)

FDA Label Image

Arformoterol-pouch.jpg (Arformoterol Pouch)

This text provides detailed information about a medication called Arformoterol Tartrate Inhalation Solution. It comes in a 2 mL Sterile Unit-Dose Vial, with each vial containing 15 mcg of arformoterol. The solution is for oral inhalation only and must be administered by opening the foil pouch just before use. It should be stored in a refrigerator but can also be stored at room temperature for up to 6 weeks. The potency is expressed as arformaterol mcg /2 ITIL Rx only. The solution should be discarded if not colorless and must be used as directed by a physician. The expiration date is important, and patients should not exceed the recommended dosage.*

FDA Label Image

Arformoterol-str.jpg (Arformoterol Str)

FDA Label Image

Arformoterol-vial.jpg (Arformoterol Vial)

This is a description of Arformoterol Tartrate Inhalation Solution in a 2 mL vial with a potency of 15 mcg/2 mL. It is sterile and made in India, intended for oral inhalation use. The product is labeled with a specific NDC code and a manufacturing date of 28/357/2006. The potency is expressed as arformoterol USL-ML14-082.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.